Replies to post #4702 on Biotech Values

[DewDiligence]

>> What's odd is that the earlier Reuters story says that 40% of patients lost more than 10% of their body weight after one year, yet the story you quote says that only ("nearly") 33% of the patients on the drug for two years lost more than 10% of their body weight. <<

The drug wasn’t quite as effective at two years as it was at one year –why is that odd?